摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl (Z)-2,5-dimethyl-2,4-hexadienoate | 76232-39-8

中文名称
——
中文别名
——
英文名称
methyl (Z)-2,5-dimethyl-2,4-hexadienoate
英文别名
1-carbomethoxy-1-methyl-4,4-dimethylbutadiene;methyl (2Z)-2,5-dimethylhexa-2,4-dienoate;2-methoxycarbonyl-5-methyl-2,4-hexadiene
methyl (Z)-2,5-dimethyl-2,4-hexadienoate化学式
CAS
76232-39-8
化学式
C9H14O2
mdl
——
分子量
154.209
InChiKey
JWSLVXSFLAYZKU-VURMDHGXSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    204.2±9.0 °C(Predicted)
  • 密度:
    0.921±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    11
  • 可旋转键数:
    3
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.44
  • 拓扑面积:
    26.3
  • 氢给体数:
    0
  • 氢受体数:
    2

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    methyl (Z)-2,5-dimethyl-2,4-hexadienoate 、 sodium hydroxide 作用下, 以 甲醇 为溶剂, 反应 12.0h, 以97%的产率得到(2Z)-2,5-dimethylhexa-2,4-dienoic acid
    参考文献:
    名称:
    通过立体选择性分子内捕获 η3-烯丙基钯中间体终止催化不对称 Heck 环化:(-)-螺环前列腺素 B 和三种立体异构体的全合成
    摘要:
    催化分子内 Heck 反应,然后通过束缚的二酮哌嗪捕获所得的 η 3 -烯丙基钯中间体,是 (-)-螺环前列腺素 B 和三种立体异构体的简洁合成路线中的核心步骤。该研究表明,在催化不对称 Heck 环化中产生的无环手性 η 3 -烯丙基钯片段,即使是弱亲核性的二酮哌嗪也可以比非对映体平衡更快地捕获。
    DOI:
    10.1016/j.tet.2010.05.048
  • 作为产物:
    描述:
    3-甲基-2-丁烯醛bis(2,2,2-trifluoroethyl) 1-(methoxycarbonyl)ethylphosphonate18-冠醚-6双(三甲基硅烷基)氨基钾 作用下, 以 四氢呋喃甲苯 为溶剂, 以86%的产率得到methyl (Z)-2,5-dimethyl-2,4-hexadienoate
    参考文献:
    名称:
    通过立体选择性分子内捕获 η3-烯丙基钯中间体终止催化不对称 Heck 环化:(-)-螺环前列腺素 B 和三种立体异构体的全合成
    摘要:
    催化分子内 Heck 反应,然后通过束缚的二酮哌嗪捕获所得的 η 3 -烯丙基钯中间体,是 (-)-螺环前列腺素 B 和三种立体异构体的简洁合成路线中的核心步骤。该研究表明,在催化不对称 Heck 环化中产生的无环手性 η 3 -烯丙基钯片段,即使是弱亲核性的二酮哌嗪也可以比非对映体平衡更快地捕获。
    DOI:
    10.1016/j.tet.2010.05.048
点击查看最新优质反应信息

文献信息

  • Chiral copper complex catalyst composition and asymmetric production process using the same
    申请人:——
    公开号:US20010037036A1
    公开(公告)日:2001-11-01
    There is disclosed chiral copper complex catalyst composition, which is obtained by contacting an optically active N-salicylideneaminoalcohol compound of formula (1): 1 with a mono-valent or di-valent copper compound in an inert solvent, wherein R 1 and R 2 represent an alkyl group and the like, X 1 and X 2 represent a hydrogen atom, a halogen atom, a nitro group, an alkyl group, an alkoxy group, a cyano group or the like, and the amount of the mono-valent or di-valent copper compound is less than 1 mole per 1 mole of the optically active N-salicylideneaminoalcohol compound of formula (1), and a process for producing an optically active cylopropane-carboxylic acid ester using the same.
    披露了手性铜配合物催化剂组合物,该组合物是通过将式(1)中的光学活性N-水杨醛亚氨基醇化合物与一价或二价铜化合物在惰性溶剂中接触而获得的,其中R1和R2代表烷基基团等,X1和X2代表氢原子、卤素原子、硝基团、烷基基团、烷氧基团、氰基团等,一价或二价铜化合物的量小于1摩尔与式(1)中的光学活性N-水杨醛亚氨基醇化合物的摩尔比,以及使用该组合物生产光学活性环丙烷羧酸酯的方法。
  • Asymmetric copper complex and cyclopropanation reaction using the same
    申请人:——
    公开号:US20020177718A1
    公开(公告)日:2002-11-28
    There are disclosed asymmetric copper complex comprising, as components, (a) an optically active bisoxazoline compound of formula (1): 1 wherein R 1 and R 2 are different and each represent a hydrogen atom, an alkyl group, a cycloalkyl group, or a phenyl or aralkyl group which may be substituted, R 3 and R 4 each represent a hydrogen atom, an alkyl group, a cycloalkyl group, or a phenyl or aralkyl group which may be substituted, or R 3 and R 4 may be bonded to each other to form a C 3-5 cyclic alkylene group, R 5 represents a hydrogen atom or a C 1-6 alkyl group, or the two R 5 groups may be bonded to each other to represent a C 3-5 cyclic alkylene group, (b) a monovalent or divalent copper compound, and (c) a strong acid or a Lewis acid or a mixture thereof, and a process for producing an optically active cyclopropanecarboxylate using the same.
    揭示了包括以下组分的不对称铜络合物:(a)公式(1)的手性双噁唑啉化合物:其中R1和R2不同,每个代表氢原子、烷基、环烷基、苯基或芳基烷基,可能被取代,R3和R4每个代表氢原子、烷基、环烷基、苯基或芳基烷基,可能被取代,或者R3和R4可以相互连接形成C3-5环烷基,R5代表氢原子或C1-6烷基,或者两个R5基团可以相互连接形成C3-5环烷基;(b)一价或二价铜化合物;和(c)强酸或Lewis酸或二者混合物,以及使用它们制备手性环丙烷羧酸酯的方法。
  • INSULIN ANALOGUES
    申请人:Robinson Andrea
    公开号:US20120225811A1
    公开(公告)日:2012-09-06
    A dicarba analogue of insulin comprising an A-chain and a B-chain or fragments, salts, solvates, derivatives, isomers or tautomers of the A-chain, the B-chain or both, provided that the dicarba analogue is not [A7,B7-(2,7-diaminosuberoyl]-des-(B26-B30)-insulin B25-amide.
    一种二卡巴胰岛素类似物,包括A链和B链或其片段,盐,溶剂化合物,衍生物,同分异构体或互变异构体,但前提是该二卡巴类似物不是[A7,B7-(2,7-二氨基戊二酰基)-去除(B26-B30)-胰岛素B25酰胺。
  • Chiral copper complex and production processes thereof and using the same
    申请人:Kamitamari Masashi
    公开号:US20050090684A1
    公开(公告)日:2005-04-28
    There is disclosed an optically active salicylideneaminoalcohol compound of formula (1): wherein R 1 represents an alkyl group or the like, R 2 represents an aryl group and the like, and when X 1 represents a nitro, X 2 is a hydrogen atom, when X 1 represents a chlorine atom, X 2 is a chlorine atom, and when X 1 is a hydrogen atom, X 2 is a fluorine atom; and the carbon atom denoted by “*” is an asymmetric carbon atom having either an S or R configuration, and a chiral copper complex produced from the optically active salicylidenaminoalcohol compound and a copper compound.
    公开了一种光学活性的萨利基利丙氨醇化合物,其化学式为(1):其中,R1代表烷基或类似物,R2代表芳基或类似物,当X1代表硝基时,X2是氢原子,当X1代表氯原子时,X2是氯原子,当X1是氢原子时,X2是氟原子;而由光学活性萨利基利丙氨醇化合物和铜化合物制备的手性铜络合物中,用“*”表示的碳原子是具有S或R构型的不对称碳原子。
  • Optically active bisoxazoline compounds, process for production of the same and use thereof
    申请人:Itagaki Makoto
    公开号:US20060149077A1
    公开(公告)日:2006-07-06
    Optically active bisoxazoline compounds represented by the general formula (1), a process for producing the compounds, and a process for producing cyclopropanecarboxylic esters by using the same: wherein R 1 and R 2 are the same and each represents C 1-6 alkyl, substituted or unsubstituted aralkyl, or substituted or unsubstituted phenyl or R 1 and R 2 are bonded each other together with the carbon atom of oxazoline ring to which they are bonded to form a ring; R 3 is substituted or unsubstituted naphthyl; R 4 and R 5 are the same and each represent hydrogen or C 1-6 alkyl, or R 4 and R 5 are bonded each other together with the carbon atom to which they are bonded to form a cycloalkyl ring having 3 to 6 carbon atoms; and * represents an asymmetric center.
    光学活性的双噁唑啉化合物由通式(1)表示,制备该化合物的方法以及使用该化合物制备环丙烷羧酸酯的方法: 其中,R1和R2相同,分别表示C1-6烷基,取代或未取代的芳基烷基或取代或未取代的苯基,或者R1和R2相互结合形成环,与它们所连接的噁唑环的碳原子相连;R3是取代或未取代的萘基;R4和R5相同,分别表示氢或C1-6烷基,或者R4和R5相互结合形成有3至6个碳原子的环状烷基环;*表示一个不对称中心。
查看更多